AVTX
Avalo Therapeutics Inc.
$11.70
-$0.13(-1.10%)
90
Overall
80
Value
100
Tech
--
Quality
Market Cap
$155.59M
Volume
262.02K
52W Range
$3.39 - $16.00
Target Price
$33.67
EPS Estimates Overview
| Current Quarter | $-1.67 | Next Quarter | $-1.47 |
| Current Year | $-5.8 | Next Year | $-5.29 |
| QoQ Growth | +12.0% | YoY Growth | +8.8% |
| 3Y EPS CAGR | +91.8% | Target Price | $33.67 |
| Consensus | Buy | Upside | +187.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $11.70 | -1.1% | 262.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |